Logo image of ATEME.PA

ATEME SA (ATEME.PA) Stock Fundamental Analysis

EPA:ATEME - Euronext Paris - Matif - FR0011992700 - Common Stock - Currency: EUR

5.74  +0.04 (+0.7%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ATEME. ATEME was compared to 26 industry peers in the Communications Equipment industry. ATEME may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ATEME is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ATEME has reported negative net income.
In the past year ATEME had a positive cash flow from operations.
In the past 5 years ATEME reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ATEME reported negative operating cash flow in multiple years.
ATEME.PA Yearly Net Income VS EBIT VS OCF VS FCFATEME.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

ATEME has a Return On Assets (-4.54%) which is comparable to the rest of the industry.
The Return On Equity of ATEME (-16.00%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.54%
ROE -16%
ROIC N/A
ROA(3y)-2.76%
ROA(5y)-1.47%
ROE(3y)-8.87%
ROE(5y)-4.9%
ROIC(3y)N/A
ROIC(5y)N/A
ATEME.PA Yearly ROA, ROE, ROICATEME.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

The Gross Margin of ATEME (57.97%) is better than 69.23% of its industry peers.
ATEME's Gross Margin has been stable in the last couple of years.
ATEME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.28%
GM growth 5Y1.27%
ATEME.PA Yearly Profit, Operating, Gross MarginsATEME.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

ATEME does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATEME has been increased compared to 1 year ago.
The number of shares outstanding for ATEME has been increased compared to 5 years ago.
The debt/assets ratio for ATEME has been reduced compared to a year ago.
ATEME.PA Yearly Shares OutstandingATEME.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ATEME.PA Yearly Total Debt VS Total AssetsATEME.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.49, we must say that ATEME is in the distress zone and has some risk of bankruptcy.
ATEME has a Altman-Z score (1.49) which is in line with its industry peers.
ATEME has a debt to FCF ratio of 17.15. This is a negative value and a sign of low solvency as ATEME would need 17.15 years to pay back of all of its debts.
The Debt to FCF ratio of ATEME (17.15) is worse than 61.54% of its industry peers.
A Debt/Equity ratio of 0.74 indicates that ATEME is somewhat dependend on debt financing.
ATEME has a Debt to Equity ratio of 0.74. This is in the lower half of the industry: ATEME underperforms 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 17.15
Altman-Z 1.49
ROIC/WACCN/A
WACC5.65%
ATEME.PA Yearly LT Debt VS Equity VS FCFATEME.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.49 indicates that ATEME should not have too much problems paying its short term obligations.
ATEME has a Current ratio (1.49) which is comparable to the rest of the industry.
ATEME has a Quick Ratio of 1.37. This is a normal value and indicates that ATEME is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.37, ATEME is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.37
ATEME.PA Yearly Current Assets VS Current LiabilitesATEME.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

The earnings per share for ATEME have decreased strongly by -33.46% in the last year.
Looking at the last year, ATEME shows a decrease in Revenue. The Revenue has decreased by -6.53% in the last year.
Measured over the past years, ATEME shows a small growth in Revenue. The Revenue has been growing by 7.11% on average per year.
EPS 1Y (TTM)-33.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%527.35%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y5.87%
Revenue growth 5Y7.11%
Sales Q2Q%3.55%

3.2 Future

ATEME is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 78.17% yearly.
The Revenue is expected to grow by 8.06% on average over the next years. This is quite good.
EPS Next Y147.71%
EPS Next 2Y78.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.67%
Revenue Next 2Y7.8%
Revenue Next 3Y8.06%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ATEME.PA Yearly Revenue VS EstimatesATEME.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ATEME.PA Yearly EPS VS EstimatesATEME.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATEME. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 21.43, the valuation of ATEME can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as ATEME.
When comparing the Price/Forward Earnings ratio of ATEME to the average of the S&P500 Index (35.28), we can say ATEME is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 21.43
ATEME.PA Price Earnings VS Forward Price EarningsATEME.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ATEME is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
ATEME's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 30.97
EV/EBITDA 350.3
ATEME.PA Per share dataATEME.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ATEME's earnings are expected to grow with 78.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y78.17%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ATEME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ATEME SA

EPA:ATEME (8/7/2025, 7:00:00 PM)

5.74

+0.04 (+0.7%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)07-17 2025-07-17
Earnings (Next)10-30 2025-10-30
Inst Owners22.34%
Inst Owner ChangeN/A
Ins Owners25.61%
Ins Owner ChangeN/A
Market Cap66.53M
Analysts86
Price Target7.65 (33.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)-1.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.43
P/S 0.71
P/FCF 30.97
P/OCF 17.01
P/B 1.98
P/tB 7.76
EV/EBITDA 350.3
EPS(TTM)-0.47
EYN/A
EPS(NY)0.27
Fwd EY4.67%
FCF(TTM)0.19
FCFY3.23%
OCF(TTM)0.34
OCFY5.88%
SpS8.07
BVpS2.9
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.54%
ROE -16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.97%
FCFM 2.3%
ROA(3y)-2.76%
ROA(5y)-1.47%
ROE(3y)-8.87%
ROE(5y)-4.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.28%
GM growth 5Y1.27%
F-Score3
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 17.15
Debt/EBITDA 92.65
Cap/Depr 42.02%
Cap/Sales 1.89%
Interest Coverage N/A
Cash Conversion 1459.7%
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 1.37
Altman-Z 1.49
F-Score3
WACC5.65%
ROIC/WACCN/A
Cap/Depr(3y)51.6%
Cap/Depr(5y)53.6%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%527.35%
EPS Next Y147.71%
EPS Next 2Y78.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y5.87%
Revenue growth 5Y7.11%
Sales Q2Q%3.55%
Revenue Next Year6.67%
Revenue Next 2Y7.8%
Revenue Next 3Y8.06%
Revenue Next 5YN/A
EBIT growth 1Y-63.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year296.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y236.99%
FCF growth 3YN/A
FCF growth 5Y-12.09%
OCF growth 1Y522.93%
OCF growth 3YN/A
OCF growth 5Y-6.11%